We designed our studies to test the hypotheses that the first productively and latently infected cells in Fiebig I would be resting CD4+ T cells, reflecting susceptible target cell availability and spatial proximity before activation of a detectable immune response at the earliest detectable stage of HIV infection and that HIV-producing resting CD4+ T cells would persist during ART. This evidence concerns the gene CD4 and HIV infectious disease.